S&P 500 7412.84 +0.19%
NASDAQ 26274.12 +0.10%
TASI 11166.83 +0.08%
Oil (WTI) 101.05 +3.04%
Oil (Brent) 106.82 +2.50%
VIX 18.85 +2.56%
Gold 4709.30 -0.41%
USD/SAR 3.75 +0.01%

HCA Healthcare, Inc.

HCA · Healthcare · · USD
426.37 USD
0.00 (-2.03%)
● Updated 2026-05-12 11:49 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score SELL Mid-term (Position)

45
/ 100
Technical 25
Trend & RS 54
Momentum 27
Fundamental 33
Macro 65
Liquidity 69
ComponentScoreWeight
Technical 25.0 20%
Trend & RS 54.1 30%
Momentum 27.3 15%
Fundamental 33.3 10%
Macro 65.1 20%
Liquidity 69.3 5%

Trade Setup

Entry 426.37
Stop Loss 400.35 (6.1%)
Target 1 (1:1) 452.39 (+6.1%)
Target 2 (2:1) 478.41 (+12.2%)
ATR(14) 13.01 (3.0%)
Risk per Share 26.02
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 78.5 +1.14
Momentum 24.8 -1.01
Quality 23.7 -1.05
Composite 42.3

Quality Scores

Piotroski F-Score 3 /9 — Weak
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

MetricStockSectorvs Peers
P/E Ratio 14.7 22.0 -33% below
P/B Ratio -15.1 4.0 Inline
Dividend Yield 73.0% 1.5% Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Fairly Valued

Intrinsic Value
395.86
vs
Market Price
426.37
Upside
-7.2%
Margin of Safety -7.7%
Stage 1 PV (5yr FCF)22,621,056,520
Terminal Value PV65,196,704,498
Total Enterprise Value87,817,761,018

Assumptions

Base FCF5,153,782,456
Growth Rate (5yr)4.3%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
28.82%
Full Kelly
14.41%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 45/100. Estimated win rate 54%, avg win 7.7%, avg loss 4.1%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG SELL

1
Bullish Signals
3
Bearish Signals
32.12
RSI(14)
-16.788
MACD

Relative Strength (RS) WEAKENING

72
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY ↓ FALLING (-21.0% vs SPY 3M)
RS vs Sector UNDERPERFORMING (Healthcare)
RS New High No (40d since high)
Sector Outperformance -11.6% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
WEAKENING: Losing momentum — the stock was performing well but is now falling behind the market.

Technical Indicators

IndicatorValueSignal
Rsi 32.12 NEUTRAL
Macd -16.788 BEARISH
Ma Cross 484.36 / 458.57 GOLDEN CROSS
Trend Short BELOW SMA50
Trend Long BELOW SMA200
Bollinger MIDDLE
Volume 1.82x HIGH

Key Levels

LevelPrice
52-Week High556.52
Bollinger Upper503.57
SMA(200)458.57
SMA(50)484.36
SMA(20)452.07
Current Price426.37
Bollinger Lower400.57
52-Week Low330.00
ATR(14)13.01

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKDOWN Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 0.0  |  Markdown: 2.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-05-05 No Demand 0.58x Low volume, narrow spread, weak close — no buying interest
2026-05-06 Normal 0.89x Normal bar — no special VSA pattern
2026-05-07 Normal 0.63x Normal bar — no special VSA pattern
2026-05-08 Normal 1.3x Normal bar — no special VSA pattern
2026-05-11 Normal 1.82x Normal bar — no special VSA pattern

Ichimoku Cloud BEARISH

LineValueStatus
Tenkan-sen (9) 431.20 Below Kijun
Kijun-sen (26) 466.45 Base line
Senkou A 448.83 Leading span A
Senkou B 488.23 Leading span B
Cloud 448.83 – 488.23 Bearish (Red)
Price vs Cloud 426.37 Below Cloud
Chikou Span 483.92 Bearish
Alignment Score 0/4 BEARISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BEARISH
BB: 400.57 – 503.57  |  KC: 431.2 – 472.94

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bullish RSI 6
Regular Bullish RSI 10

Anchored VWAP

VWAP: 454.75 Anchor: 2025-07-25 (52w Low) BELOW AVWAP -6.2%

Heikin-Ashi Trend

EXHAUSTION Trend exhaustion (3 doji candles) Full data via /api/advanced/HCA

Valuation

MetricValue
Market Cap94.59B
P/E (TTM)14.68
Forward P/EN/A
P/B-15.05
EPS29.04

Financial Health

MetricValue
Revenue Growth4.3%
Profit Margin8.9%
ROEN/A
Debt/EquityN/A
Current Ratio0.83
Dividend Yield73.0%
Payout RatioN/A
Beta1.19

Trading Data

426.37
Open
426.37
Day High
426.37
Day Low
1.77M
Volume (1.6x avg)

Recent News (8)

Is It Time To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Simply Wall St. · 2026-05-07
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View
Zacks · 2026-05-06
Encompass Health Q1 EPS Tops, Revenues Climb on Solid Discharges
Zacks · 2026-05-06
ENSG Tops Q1 EPS Estimates on Patient Growth, Raises '26 Outlook
Zacks · 2026-05-05
Pediatrix Medical Q1 Earnings Beat Estimates on Same-Unit Strength
Zacks · 2026-05-05
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness
Zacks · 2026-05-04
Possible Bearish Signals With HCA Healthcare Insiders Disposing Stock
Simply Wall St. · 2026-05-03
The 5 Most Interesting Analyst Questions From HCA Healthcare’s Q1 Earnings Call
StockStory · 2026-05-02

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —